Amantadine in unvaccinated patients with early, mild to moderate COVID-19: a randomized, placebo-controlled, double-blind trial.

Konrad RejdakPiotr FiedorRobert BonekJacek ŁukasiakWaldemar ChełstowskiSławomir KiciakPiotr DąbrowskiAgnieszka Gala-BłądzińskaMateusz DecEwa PapućAdriana ZasybskaMarcin KaczorPaweł Griebnull null

Published in: European journal of neurology (2023)

The central effects on the nervous system with reduction of sleepiness and depression might have had a supportive effect on faster recovery in early COVID-19 patients.

Keyphrases

placebo controlled
double blind
phase iii
sars cov
phase ii
study protocol
clinical trial
coronavirus disease
sleep quality
obstructive sleep apnea
depressive symptoms
open label
sleep apnea
squamous cell carcinoma